Cosmetic iris implants

Iris prosthetic devices offer significant benefit in patients with iris defects with subsequent glare and light sensitivity. These devices are properly made and properly placed devices and have been shown to have excellent results. The same cannot be said for cosmetic iris implants, unapproved devices for which patients are travelling to Panama to change the colour of the iris, typically to blue. Researchers at the New York Eye and Ear Infirmary report a case series highlighting some of the serious problems associated with the implants. The report covers 14 eyes of seven patients who received the NewColorIris cosmetic iris implants. Nine eyes presented with decreased visual acuity, seven had elevated IOP, five had corneal oedema, and five had anterior uveitis. All 14 eyes had explantation of the iris prosthesis. Intraoperative complications included suprachoroidal haemorrhage during explantation in one eye. Postoperative complications included corneal oedema, cataract, and increased IOP/glaucoma. In an accompanying editorial, Dr Nick Mamalis calls for both patients and physicians to seriously reconsider the use of this cosmetic iris implant device in healthy phakic eyes. A Hoguet et al., JCRS, “Serious ocular complications of cosmetic iris implants in 14 eyesâ€,
Volume 38, Issue 3, 387-393.
N Mamalis, “Cosmetic iris implantsâ€, Volume 38, Issue 3, 383.
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.
Should Fuchs’ Dystrophy Patients Get Premium Lenses?
Patients’ demand for premium IOLs despite contraindications pose a challenge in Fuchs’ dystrophy treatment.
Avoiding Posterior Capsule Rupture
Imaging may help, but surgical technique is key for managing posterior polar cataracts.